课题基金 / 基金详情

TOPIC 453: THE PERFECT MEDICAL ASSISTANT FOR CANCER PREVENTION WITHIN PRIMARY CARE

TOPIC 453: THE PERFECT MEDICAL ASSISTANT FOR CANCER PREVENTION WITHIN PRIMARY CARE
主题 453:初级保健中预防癌症的完美医疗助手
批准号:
10931123
负责人:
STEVEN CHARLAP
金额:
$40.0万
依托单位:
依托单位国家:
美国
项目类别:
财政年份:
2023
资助国家:
美国
项目状态:
已结题
起止时间:
2023-09-18 至 2024-09-17

项目摘要

项目成果

相似基金

相关文献

中文摘要
翻译
癌症是美国第二大也是最昂贵的死因。由于每年有超过5亿人次就诊于初级保健医生,通过识别初级保健环境中的高危个人来预防和及早发现癌症,可以显著降低个人和整个社会的癌症护理和成本负担。完美医疗助理™M(PMA)是一款获得专利的对话式语音和图像软件应用程序,可收集和评估患者数据,可帮助初级保健医生改进对高危患者的识别并提高他们的工作效率。 在第一阶段,我们将展示PM有效地克服了PCP广泛采用的两个主要障碍,1.患者接受度和可用性2.轻松集成到医生工作流程中,并且不会中断。 目的1.通过对多达400名受激励但不同的患者进行测试,证明PMA在潜在患者用户群体中的可行性和可接受性。 目的2.通过将PMA和生成的SOAP(主观、客观、评估、计划)格式的临床记录整合到两个至少25个PCP的PCP实践的HRs中,证明可以将PMA和生成的SOAP(主观、客观、评估、计划)格式的临床记录整合到PCP的电子健康记录系统和工作流程中,作为主要的患者接收和癌症风险评估工具。
英文摘要
Cancer is the second leading and the most expensive cause of death in the United States. With more than 500 million visits a year made to primary care physicians, prevention and early detection of cancer by identification of at-risk individuals in the primary care setting can significantly reduce the cancer care and cost burden to individuals and society at large. The Perfect Medical Assistant ™M (PMA), a patented, conversational Al-powered voice and image-based software application that collects and assesses patient data can assist primary care physicians to improve identification of at-risk patients and improve their productivity. In Phase I, we will demonstrate that the PM effectively overcomes the two major barriers to widespread adoption by PCPs, 1. patient acceptance and usability 2. easy integration into and no-disruption of physician workflows. AIM 1. Demonstrate the feasibility and acceptability of the PMA in a population of potential patient users by testing on up to 400 incentivized, but diverse patients. AIM 2. Demonstrate that the PMA and the generated SOAP (Subjective, Objective, Assessment, Plan) formatted clinical note can be integrated into PCPs' electronic health record systems and workflows as the primary patient intake and cancer risk assessment tool by integrating into the HRs of two PCP practices of at least 25 PCPs each.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
国内基金
海外基金
扶正消癥汤对乳腺癌MCF-7、MDA-MB453、MDA-MB231细胞亚结构及h-TERT表达的影响
  • 批准号:
    2022J011334
  • 项目类别:
    省市级项目
  • 资助金额:
    10.0万元
  • 批准年份:
    2022
  • 负责人:
    钱之远
  • 依托单位:
胃癌中PIK3CA非热点突变E453K上调PD-L1的机制研究
  • 批准号:
    81672397
  • 项目类别:
    面上项目
  • 资助金额:
    57.0万元
  • 批准年份:
    2016
  • 负责人:
    勾红峰
  • 依托单位:
黑米花青素对HER-2/neu高表达乳腺癌血管生成的抑制作用及机理研究